SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-092265
Filing Date
2022-04-01
Accepted
2022-03-31 19:20:03
Documents
12
Period of Report
2022-03-31
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d330903d8k.htm   iXBRL 8-K 23515
  Complete submission text file 0001193125-22-092265.txt   141232

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ttoo-20220331.xsd EX-101.SCH 2871
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttoo-20220331_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttoo-20220331_pre.xml EX-101.PRE 10822
6 EXTRACTED XBRL INSTANCE DOCUMENT d330903d8k_htm.xml XML 3282
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 22795060
SIC: 3841 Surgical & Medical Instruments & Apparatus